MyFinsight
Home
Blog
About
Convertible notes payable
$365,395
(463.71%↑ Y/Y)
something is missing
$341,220
Loan payable
$116,285
(29.21%↑ Y/Y)
Capital stock
$239
(261.49%↑ Y/Y)
Net cash provided by
financing activities
$533,299
(214.91%↑ Y/Y)
Canceled cashflow
$289,840
Net cash increase
(decrease) for period
$60,441
(185.14%↑ Y/Y)
Canceled cashflow
$472,858
Loan from related
parties
-$129,756
(-208.30%↓ Y/Y)
Due from
subsidiaries
-$100,757
Additional paid in capital
-$59,327
(-199.12%↓ Y/Y)
Accounts payable
$137,039
(-42.61%↓ Y/Y)
Amortization
$5,244
(-19.55%↓ Y/Y)
Net cash used in
operating activities
-$414,258
(-72.36%↓ Y/Y)
Net cash used in
investing activities
-$58,600
Canceled cashflow
$142,283
Net loss
-$552,041
(-13.22%↓ Y/Y)
Api acquisition
-$58,600
Prepaid expenses
-$4,500
(-333.16%↓ Y/Y)
Back
Back
Cash Flow
AVAI BIO, INC. (AVAI)
AVAI BIO, INC. (AVAI)
source: myfinsight.com